Patent Applications and Protection of Traditional Medicine under the Global Intellectual Property Law Framework
DOI:
https://doi.org/10.54097/ejgwm474Keywords:
Traditional Medicine, Patent Protection, BiopiracyAbstract
Traditional medicine is deeply rooted in different cultures and remains an important global medical resource. However, the intellectual property protection of traditional medicines faces significant challenges in the global legal framework. Issues such as biopiracy, lack of novelty, difficulties in attribution and inconsistent national implementation hinder the effective patenting of traditional medical knowledge (TMK). This paper examines current international IP regimes relevant to TMK, including the Patent Cooperation Treaty (PCT), the Convention on Biological Diversity (CBD), and the Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS). By analyzing case studies from China, India and Peru, this study identifies gaps in the legal framework and proposes improvements such as specialized patent laws, electronic TMK files and equitable benefit-sharing mechanisms. Strengthening legal frameworks and harmonizing international policies can improve the protection of TMKs and ensure fair recognition and sustainable use for future generations.
Downloads
References
[1] World Intellectual Property Organization, 'Intellectual Property and Traditional Medical Knowledge' (Report, 2016).
[2] Nan Xia, ‘Intellectual Property Protection for Traditional Medical Knowledge in China’s Context: A Round Peg in a Square Hole?’ (2023) 31 Medical Law Review 358.
[3] Kai Liu et al., 'Intellectual Property Rights and Access to Medicine in the Traditional Chinese Medicine Legal System: From a Chinese Perspective' (2019) 38(3) Medicine and Law 443.
[4] Ryan Abbott, 'Documenting Traditional Medical Knowledge' (Report, World Intellectual Property Organization, March 2014).
[5] Patent Cooperation Treaty, opened for signature 19 June 1970, 1160 UNTS 231 (entered into force 24 January 1978).
[6] Convention on Biological Diversity, opened for signature 5 June 1992, 1760 UNTS 79 (entered into force 29 December 1993).
[7] Agreement on Trade-Related Aspects of Intellectual Property Rights, opened for signature 15 April 1994, 1869 UNTS 299 (entered into force 1 January 1995).
[8] World Health Organization, World Intellectual Property Organization, and World Trade Organization, Promoting Access to Medical Technologies and Innovation: Intersections between Public Health, Intellectual Property and Trade (World Health Organization, 2013).
[9] Yue Xu and Yumao Wang, "IP Protection of Traditional Knowledge: A Dilemma Faced by the Chinese Traditional Medicine in Global Competition" in Intellectual Property – Global Perspective Advances and Challenges (IntechOpen, 2023) 10.
[10] Karin Timmermans, "Intellectual Property Rights and Traditional Medicine: Policy Dilemmas at the Interface" (2003) 57(4) Social Science & Medicine 745.
[11] Cislé Stella Jacobs, Patents of Traditional Medicine Inventions and their Relationship with Traditional Knowledge Associated with Genetic Resources in Namibia: Proposals for Legal Reform (LLM Dissertation, University of Cape Town, 2017) 14.
[12] Law of the People's Republic of China on Traditional Chinese Medicine, Presidential Order No 59 of 2016 (China) 25 December 2016, commenced 1 July 2017.
[13] Regulations on the Protection of Chinese Materia Medica (People's Republic of China) National Administration of Traditional Chinese Medicine Order, February 2023.
[14] Nagoya Protocol on Access to Genetic Resources and the Fair and Equitable Sharing of Benefits Arising from their Utilization to the Convention on Biological Diversity, opened for signature 29 October 2010, 3008 UNTS 3 (entered into force 12 October 2014) art 5.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Academic Journal of Management and Social Sciences
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
